scholarly article | Q13442814 |
P50 | author | Azra Ghani | Q60550218 |
Robert G. Will | Q118106031 | ||
P2093 | author name string | Paul Clarke | |
P2860 | cites work | The same prion strain causes vCJD and BSE | Q57092996 |
Long-term survival after blood transfusion: a population based study in the North of England | Q80260178 | ||
Where does blood go? Prospective observational study of red cell transfusion in north England | Q34148352 | ||
On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations | Q34155650 | ||
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient | Q34339769 | ||
Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies | Q34489473 | ||
Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study | Q34622879 | ||
Subclinical prion infection in humans and animals | Q35548998 | ||
Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty. | Q36302930 | ||
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease | Q36346109 | ||
Clinical implications of emerging pathogens in haemophilia: the variant Creutzfeldt-Jakob disease experience | Q36381542 | ||
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study | Q36588347 | ||
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans | Q36782262 | ||
Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instruments | Q39018369 | ||
BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein | Q39686522 | ||
Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility | Q40306174 | ||
Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier | Q40624584 | ||
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. | Q43220422 | ||
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent | Q44592404 | ||
Pathogenesis of mouse scrapie: Effect of route of inoculation on infectivity titres and dose-response curves | Q45177416 | ||
Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. | Q47278870 | ||
Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. | Q50789460 | ||
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. | Q51037857 | ||
Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. | Q52226096 | ||
Predicted vCJD mortality in Great Britain | Q56830897 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | epidemic | Q44512 |
Creutzfeldt-Jakob disease | Q49989 | ||
P304 | page(s) | 675-684 | |
P577 | publication date | 2007-08-01 | |
P1433 | published in | Journal of the Royal Society Interface | Q2492390 |
P1476 | title | Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? | |
P478 | volume | 4 |
Q35875915 | Could immunomodulation be used to prevent prion diseases? |
Q39018369 | Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instruments |
Q26741073 | Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use |
Q34565644 | Immunomodulation for prion and prion-related diseases |
Q55005212 | Initial Results of a Prospective Study and Identification of New Strategies to Increase Traceability of Plasma-derived Medicines. |
Q90163542 | PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease |
Q36732837 | Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease |
Q34086359 | Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated Septembe |
Q50475230 | Risk assessment for transmission of variant Creutzfeldt-Jakob disease by transfusion of red blood cells in the United States. |
Q33784392 | Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. |
Search more.